Multimodal Analysis of Transcriptional Regulation in the Dorsolateral Prefrontal Cortex Enhances Alzheimer's Disease Risk Gene Discovery
- 1Emory University
Abstract
Recent transcriptome-wide association studies (TWASs) of Alzheimer's disease (AD) dementia have identified risk genes whose effects are potentially mediated through gene expression, but most do not consider other transcriptomic regulatory modalities that may contribute to AD genetic risk. To address this gap, we profiled transcriptomic quantitative traits across six modalities--gene expression, RNA stability, isoform ratios, splice junction usage, alternative TSS and polyA usage--from dorsolateral prefrontal cortex RNA-seq data tissue (n=1,035). We profiled 396,344 transcriptomic traits, which we leveraged for quantitative trait loci (xQTL) mapping and TWAS analyses of AD. We identified 25,736 xGenes (49.6% of analyzed genes) with at least one conditionally independent xQTL in separate-modality mapping, increasing signal detection by 42% relative to studying expression alone. Cross-modality mapping reduced redundant independent xQTLs by 45% while retaining signals better aligned with biological characteristics of each modality. We colocalized cross-modality xQTLs with 55 of 75 AD GWAS risk loci, including 15 risk loci detected only with non-expression modalities. TWAS analyses identified 161 independent risk genes with 59% detected through non-expression modalities and ~30% in multiple modalities. Follow-up proteome-wide association studies using DLPFC proteomic data provided proteomic support for 26 of these independent xTWAS risk genes. Protein-protein interaction analysis further showed that 46.6% of these independent xTWAS risk genes form an interconnected network through hub genes including MAPT, BIN1, and TREM2. Our study demonstrates that studying transcriptional modalities besides expression substantially enhances the detection of AD-associated genetic signals and elucidates their underlying mechanisms.
Related
- Attenuated GlycoRNA-microglial transcriptional coupling in the dorsolateral prefrontal cortex of patients with major depressive disorder: an exploratory interaction-based in-silico analysis
- Individualized, parcel-guided rTMS to the left dorsolateral prefrontal cortex for treatment resistant depression
- Epigenetic regulation of the transcriptional activity of genes mediating the neuroprotective activity of ceftriaxone in the brain in a rat model of sporadic Alzheimer disease: the involvement of histone deacetylase 1.
- Integrating dorsolateral prefrontal cortex multi-omics and GWAS summary data enhances gene-mapping of Parkinson's disease
- Repeated prefrontal transcranial direct current stimulation improves behavioral regulation and modulates resting-state EEG microstate dynamics in young adults with problematic smartphone use: a randomized sham-controlled longitudinal study
BibTeX
@misc{kim2026multimodal,
title = {{Multimodal Analysis of Transcriptional Regulation in the Dorsolateral Prefrontal Cortex Enhances Alzheimer's Disease Risk Gene Discovery}},
author = {K. Kim and Q. Liu and A. S. Buchman and S. Tasaki and D. A. Bennett and Y. Wang and P. De Jager and J. Hu and J. Yang and M. Epstein},
howpublished = {medRxiv},
year = {2026},
month = oct,
doi = {10.64898/2026.10.29.26366737},
url = {https://www.medrxiv.org/content/10.64898/2026.10.29.26366737v1},
note = {CC BY-NC-ND},
}
RIS
TY - UNPB
TI - Multimodal Analysis of Transcriptional Regulation in the Dorsolateral Prefrontal Cortex Enhances Alzheimer's Disease Risk Gene Discovery
AU - K. Kim
AU - Q. Liu
AU - A. S. Buchman
AU - S. Tasaki
AU - D. A. Bennett
AU - Y. Wang
AU - P. De Jager
AU - J. Hu
AU - J. Yang
AU - M. Epstein
PY - 2026
DA - 2026/10/29
PB - medRxiv
DO - 10.64898/2026.10.29.26366737
UR - https://www.medrxiv.org/content/10.64898/2026.10.29.26366737v1
AB - Recent transcriptome-wide association studies (TWASs) of Alzheimer's disease (AD) dementia have identified risk genes whose effects are potentially mediated through gene expression, but most do not consider other transcriptomic regulatory modalities that may contribute to AD genetic risk. To address this gap, we profiled transcriptomic quantitative traits across six modalities--gene expression, RNA stability, isoform ratios, splice junction usage, alternative TSS and polyA usage--from dorsolateral prefrontal cortex RNA-seq data tissue (n=1,035). We profiled 396,344 transcriptomic traits, which we leveraged for quantitative trait loci (xQTL) mapping and TWAS analyses of AD. We identified 25,736 xGenes (49.6% of analyzed genes) with at least one conditionally independent xQTL in separate-modality mapping, increasing signal detection by 42% relative to studying expression alone. Cross-modality mapping reduced redundant independent xQTLs by 45% while retaining signals better aligned with biological characteristics of each modality. We colocalized cross-modality xQTLs with 55 of 75 AD GWAS risk loci, including 15 risk loci detected only with non-expression modalities. TWAS analyses identified 161 independent risk genes with 59% detected through non-expression modalities and ~30% in multiple modalities. Follow-up proteome-wide association studies using DLPFC proteomic data provided proteomic support for 26 of these independent xTWAS risk genes. Protein-protein interaction analysis further showed that 46.6% of these independent xTWAS risk genes form an interconnected network through hub genes including MAPT, BIN1, and TREM2. Our study demonstrates that studying transcriptional modalities besides expression substantially enhances the detection of AD-associated genetic signals and elucidates their underlying mechanisms.
ER -